← Evidence map

ArticleThe American journal of case reports2022

Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report.

Benjamin Peter Michael Gummlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report. | Socratic